[ad_1]
UFC heavyweight Walt Harris shall be on the sidelines for the foreseeable future.
On Wednesday evening, Fight Sports activities Anti-Doping (CSAD)—the group that oversees the brand new UFC anti-doping program—introduced that Harris has accepted a four-year suspension for 2 separate violations of the promotion’s new coverage.
In keeping with the discharge, Harris examined optimistic for drostanalone, its metabolite 3a-hydroxy-2a-methyl-5a-androstan-17-on, and testosterone of exogenous origin in a pair of assessments given in June and July of 2023. After being notified of the optimistic assessments, Harris submitted “urine and blood samples” in August. Harris’s urine pattern examined optimistic for anastrozole, together with the opposite gadgets Harris beforehand examined optimistic for.
Moreover, Harris’ blood additionally examined optimistic for the presence of exogenous testosterone, in keeping with the discharge.
“Drostanolone and testosterone are anabolic steroids and prohibited always beneath the UFC Anti-Doping Coverage (UFC ADP) and UFC Prohibited Record,” the assertion reads.
Anastrozole, which is categorized as “an aromatase inhibitor,” can be prohibited always in keeping with the brand new coverage.
Harris, 40, shall be eligible to compete once more in July 2027, as his suspension started on July 11. Harris had previously accepted a one-year suspension from the Nevada Athletic Fee stemming from his optimistic take a look at in June 2023.
Ought to Harris return to compeition following the suspension, he may have been out of motion for over six years, as he final competed in June 2021, when he suffered a first-round TKO loss to Marcin Tybura — his third consecutive stoppage loss. Harris has competed 16 occasions within the octagon, and holds a promotional report of 6-9 (1 NC).
[ad_2]
Source link
